Crosby Health
AI NativeAutomate winning clinical appeals for more revenue, faster.
Est 2022
Published Jul 15, 2026
The vendor’s Terms include broad disclaimers of warranties (including accuracy and security), which underscores the need for rigorous QA and governance in clinical and financial automation. (https://www.crosbyhealth.com/terms-and-conditions?utm_source=openai)
No clear public roadmap with dated milestones was found during this research.
Some software directories include positive quotes attributed to customers describing efficiency gains after adopting Crosby Health. Such directory quotes are often vendor-submitted and are not independently verified; buyer diligence should confirm customer identity and outcomes before treating these as evidence.
Based on vendor messaging and the competitive landscape, plausible selection drivers include:
Provider organizations with meaningful prior authorization and medical necessity denial volumes: inpatient/outpatient, imaging, surgery, and specialty clinics.
Get a comprehensive analysis of Crosby Health including market position, competitive landscape, adoption trends, and peer benchmarks.
Download full report →You need mature, independently reviewed market validation today If procurement requires abundant third-party reviews (G2, TrustRadius, Gartner Peer Insights), Crosby currently shows limited public review volume.
You require clearly documented public security certifications If your security process expects SOC 2 Type II or ISO 27001 documentation upfront, Crosby’s public materials emphasize HIPAA adherence but do not document certification evidence.
You need a broad RCM platform rather than an appeals-focused workflow If priority is end-to-end claims lifecycle management and one suite vendor, alternatives such as Waystar or FinThrive may provide a broader structural fit. (https://www.waystar.com/denial-management/?utm_source=openai)
You need heavy managed services rather than software enablement If your team lacks bandwidth to operationalize new workflows, a services-forward vendor (for example, Infinx or other managed services providers) may be more effective for rapid operational throughput. (https://www.infinx.com/accounts-receivable-recovery-and-denials-management-platform/?utm_source=openai)
Implication: third-party review coverage is currently thin, making it difficult to validate performance and support claims at scale.
Based on vendor messaging (small hospitals to multi-facility health systems and private practice origins), Crosby’s ICP likely spans:
(Exact sizing is not explicitly published; this is inferred from vendor materials.) (https://www.crosbyhealth.com/features-pages/hospitals-and-health-systems?utm_source=openai)
Crosby Health provides an automation platform for clinical claim appeals that generates appeal letters, submits appeals to payers, and tracks appeal statuses and decisions to reduce provider and billing-team workload for clinical denials. The core workflow emphasizes a high-coverage appeals strategy (including small-balance claims) and consolidating payer submissions into a unified process rather than navigating multiple payer portals and fax systems.
On its website, Crosby Health describes Apollo, a model the vendor presents as a clinical language model tuned for revenue cycle management (RCM) text tasks (appeals, auditing, charge capture, denial management). The vendor states Apollo can process large documents (for example, up to 300 pages) and produce draft outputs; independent validation of these performance claims is limited.
Primary use case: denial/appeals automation for providers (hospitals, health systems, private practices). (https://www.crosbyhealth.com/?utm_source=openai)